首页>
外国专利>
A procedure for the preparation of compounds given of anti-inflammatory properties. (Machine-translation by Google Translate, not legally binding)
A procedure for the preparation of compounds given of anti-inflammatory properties. (Machine-translation by Google Translate, not legally binding)
展开▼
机译:一种具有抗炎特性的化合物的制备方法。 (通过Google翻译进行机器翻译,没有法律约束力)
展开▼
页面导航
摘要
著录项
相似文献
摘要
A process for the preparation of compounds endowed with anti-inflammatory properties, of the formula: ** (See formula) ** where R1 and R2 are both selected from the group consisting of hydrogen, halogen, trifluoromethyl, (lower) alkyl, lower alkoxy, nitro, dialkyl (lower) amino, alkanoyl (lower), phenyl, phenoxy, lower alkyl phenoxy, halofenoxy benzyloxy, lower alkyl benzyloxy, lower alkoxy benzyloxy, halobenzyloxy; R3 is selected from the group consisting of hydrogen, lower alkyl and trifluoromethyl; R 4 is selected from the group consisting of hydrogen and lower alkyl; R5 is selected from the group consisting of hydrogen, lower alkyl, trifluoromethyl, lower alkenyl, and phenyl; R6 is selected from the radicals of the formula: ** (See formula) ** wherein R7 and R8 are both selected from the group consisting of hydrogen, halogen, trifluoromethyl, lower alkyl, lower alkoxy, lower alkylthio, trifluoromethyloxy, trifluoromethylthio, phenyl, phenoxy, halofenoxy, lower alkyl phenoxy, alkoxy (lower) phenoxy, phenylthio, nitro, benzyloxy and lower alkyl benzyloxy; and pharmacologically acceptable non-toxic salts thereof; whose process consists of acylating an indolyltetrazole of the formula: ** (See formula) ** wherein R1, R2, R3, R4 and R5 are those described above, preferably in the form of their alkali metal dimethyl salts, with an equimolar weight of approximately an acid halide of the formula: ** (See formula) ** wherein R6 is that described above and X is a halogen atom, or with a functional equivalent of said acid halide, in an inert organic solvent at a temperature comprised between about -20º C and about 50º C; and, if desired, by reacting the compound in which R1 or R2 is benzyloxy or nitro with hydrogen, in the presence of a catalyst, to produce the corresponding compound where R1 or R2 is hydroxy or amino respectively. (Machine-translation by Google Translate, not legally binding)
展开▼
机译:具有以下结构的具有抗炎特性的化合物的制备方法:**(参见通式)**其中R1和R2均选自氢,卤素,三氟甲基,(低级)烷基,低级烷氧基,硝基,二烷基(低级)氨基,烷酰基(低级),苯基,苯氧基,低级烷基苯氧基,卤代苯氧基苄氧基,低级烷基苄氧基,低级烷氧基苄氧基,卤代苄氧基; R 3选自氢,低级烷基和三氟甲基; R 4选自氢和低级烷基; R5选自氢,低级烷基,三氟甲基,低级烯基和苯基; R6选自下式的基团:**(参见式)**其中R7和R8均选自氢,卤素,三氟甲基,低级烷基,低级烷氧基,低级烷硫基,三氟甲氧基,三氟甲硫基,苯基,苯氧基,卤代苯氧基,低级烷基苯氧基,烷氧基(低级)苯氧基,苯硫基,硝基,苄氧基和低级烷基苄氧基;及其药理学上可接受的无毒盐;其过程由酰化式下的吲哚基四唑组成:**(参见式)**其中R1,R2,R3,R4和R5是上述的那些,优选以其碱金属二甲基盐的形式,等摩尔重量为在惰性有机溶剂中,在约80℃至约200℃之间的温度下,其中R 6为上述基团,且X为卤原子或具有所述酰基卤的官能当量,近似为下式的酰基卤:**(参见式)** -20ºC和大约50ºC;如果需要的话,在催化剂存在下,通过使R 1或R 2为苄氧基或硝基的化合物与氢反应,制得相应的化合物,其中R 1或R 2分别为羟基或氨基。 (通过Google翻译进行机器翻译,没有法律约束力)
展开▼